• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素通过Akt级联反应诱导人卵巢癌细胞系中hTERT的表达和磷酸化。

Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.

作者信息

Kimura Akiko, Ohmichi Masahide, Kawagoe Jun, Kyo Satoru, Mabuchi Seiji, Takahashi Toshifumi, Ohshima Chika, Arimoto-Ishida Emi, Nishio Yukihiro, Inoue Masaki, Kurachi Hirohisa, Tasaka Keiichi, Murata Yuji

机构信息

Department of Obstetrics and Gynecology, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

出版信息

Oncogene. 2004 Jun 3;23(26):4505-15. doi: 10.1038/sj.onc.1207582.

DOI:10.1038/sj.onc.1207582
PMID:15048073
Abstract

We examined the mechanism by which estrogen regulates telomerase activity in Caov-3 human ovarian cancer cell lines, which express ER, to determine whether the regulation affects the expression and/or phosphorylation of the telomerase catalytic subunit (hTERT). 17beta-Estradiol (E(2)) induced telomerase activity and hTERT expression. Transient expression assays using luciferase reporter plasmids containing various fragments of hTERT promoter showed that the estrogen-responsive element appeared to be partially responsible for the E(2)-induced activation of the hTERT promoter. Either pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, or transfection with a dominant-negative Akt attenuated the E(2)-induced activation of the hTERT promoter. In addition, estrogen induced the phosphorylation of IkappaB inhibitor protein via the Akt cascade, and cotransfection with a dominant-negative subunit of NFkappaB attenuated the response of the ERE-deleted hTERT promoter to E(2). Moreover, E(2) induced the phosphorylation of hTERT, the association of 14-3-3 protein and NFkappaB with hTERT, and nuclear accumulation of hTERT in an Akt-dependent manner. These results indicate that E(2) induces telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and a PI3K/Akt/NFkappaB cascade, but also by post-transcriptional regulation via Akt-dependent phosphorylation of hTERT. Thus, the phosphorylation of Akt is a key event in the induction of telomerase activity by E(2) in human ovarian cancer cells.

摘要

我们研究了雌激素调节Caov-3人卵巢癌细胞系中端粒酶活性的机制,该细胞系表达雌激素受体(ER),以确定这种调节是否影响端粒酶催化亚基(hTERT)的表达和/或磷酸化。17β-雌二醇(E₂)诱导了端粒酶活性和hTERT表达。使用含有hTERT启动子不同片段的荧光素酶报告质粒进行的瞬时表达分析表明,雌激素反应元件似乎部分负责E₂诱导的hTERT启动子激活。用磷脂酰肌醇3激酶(PI3K)抑制剂LY294002预处理或用显性负性Akt转染均可减弱E₂诱导的hTERT启动子激活。此外,雌激素通过Akt级联反应诱导IκB抑制蛋白的磷酸化,与显性负性NFκB亚基共转染可减弱缺失雌激素反应元件(ERE)的hTERT启动子对E₂的反应。而且,E₂以Akt依赖的方式诱导hTERT的磷酸化、14-3-3蛋白和NFκB与hTERT的结合以及hTERT的核内积累。这些结果表明,E₂不仅通过依赖ERE的机制和PI3K/Akt/NFκB级联反应对hTERT进行转录调控来诱导端粒酶活性,还通过Akt依赖的hTERT磷酸化进行转录后调控。因此,Akt的磷酸化是E₂在人卵巢癌细胞中诱导端粒酶活性的关键事件。

相似文献

1
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.雌激素通过Akt级联反应诱导人卵巢癌细胞系中hTERT的表达和磷酸化。
Oncogene. 2004 Jun 3;23(26):4505-15. doi: 10.1038/sj.onc.1207582.
2
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.雷洛昔芬可抑制雌激素诱导的人乳腺癌细胞系中端粒酶活性的上调。
J Biol Chem. 2003 Oct 31;278(44):43363-72. doi: 10.1074/jbc.M304363200. Epub 2003 Aug 13.
3
Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.雌二醇对雌激素受体α基因表达和活性的影响可由ErbB2/PI 3-K/Akt信号通路调控。
Oncogene. 2003 Sep 11;22(39):7998-8011. doi: 10.1038/sj.onc.1206769.
4
IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.白细胞介素-2通过磷脂酰肌醇3'-激酶/蛋白激酶B、热休克蛋白90和雷帕霉素哺乳动物靶标,在转录和翻译后水平上增加转化自然杀伤细胞中的人端粒酶逆转录酶活性。
J Immunol. 2005 May 1;174(9):5261-9. doi: 10.4049/jimmunol.174.9.5261.
5
Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.组蛋白去乙酰化酶抑制剂 AR42 通过 Akt 依赖的机制调节人神经胶质瘤细胞端粒酶活性。
Biochem Biophys Res Commun. 2013 May 24;435(1):107-12. doi: 10.1016/j.bbrc.2013.04.049. Epub 2013 Apr 23.
6
Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells.雷洛昔芬可增加人脐静脉内皮细胞的增殖并上调端粒酶活性。
J Biol Chem. 2006 Aug 25;281(34):24270-8. doi: 10.1074/jbc.M513251200. Epub 2006 Jun 23.
7
Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.雌激素和雷洛昔芬均可通过Akt级联激活端粒酶活性,从而保护雌激素受体α转染的PC12细胞免受β-淀粉样蛋白诱导的神经毒性。
J Endocrinol. 2004 Dec;183(3):605-15. doi: 10.1677/joe.1.05775.
8
Estradiol rapidly activates Akt via the ErbB2 signaling pathway.雌二醇通过ErbB2信号通路快速激活Akt。
Mol Endocrinol. 2003 May;17(5):818-30. doi: 10.1210/me.2002-0330. Epub 2003 Jan 23.
9
AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.AND-34激活磷脂酰肌醇3-激酶,并以一种依赖于SH2和GDP交换因子样结构域的方式诱导抗雌激素耐药性。
Mol Cancer Res. 2005 Jan;3(1):32-41.
10
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.子宫内膜癌细胞中Akt对COX-2蛋白表达的调控是通过NF-κB/IκB途径介导的。
Mol Cancer. 2004 Mar 11;3:7. doi: 10.1186/1476-4598-3-7.

引用本文的文献

1
Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism.药物治疗对自闭症大鼠模型中端粒长度及端粒酶/保护素相关基因表达的影响
J Mol Neurosci. 2025 Apr 24;75(2):55. doi: 10.1007/s12031-025-02353-4.
2
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies.热休克蛋白作为癌症的标志:从分子机制到治疗策略的见解。
J Hematol Oncol. 2024 Sep 4;17(1):81. doi: 10.1186/s13045-024-01601-1.
3
Impact of khat (Catha edulis) and oral contraceptive use on telomerase levels and tumor suppressor genes p53 and p21 in normal subjects and breast cancer patients.
阿拉伯茶(巧茶)和口服避孕药对正常人群和乳腺癌患者端粒酶水平及抑癌基因 p53 和 p21 的影响。
Sci Rep. 2024 Jul 16;14(1):16365. doi: 10.1038/s41598-024-67355-5.
4
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.从端粒和端粒酶的角度理解、诊断和治疗胰腺癌。
Cancer Gene Ther. 2024 Sep;31(9):1292-1305. doi: 10.1038/s41417-024-00768-6. Epub 2024 Apr 9.
5
Relationship between telomere length and the prognosis of breast cancer based on estrogen receptor status: A Mendelian randomization study.基于雌激素受体状态的端粒长度与乳腺癌预后的关系:一项孟德尔随机化研究。
Front Oncol. 2022 Oct 21;12:1024772. doi: 10.3389/fonc.2022.1024772. eCollection 2022.
6
Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer.激素对类固醇调节组织及癌症中端粒酶活性和人端粒酶逆转录酶(hTERT)表达的调控
Cancer Cell Int. 2022 Aug 16;22(1):258. doi: 10.1186/s12935-022-02678-9.
7
Telomeres and Cancer.端粒与癌症
Life (Basel). 2021 Dec 16;11(12):1405. doi: 10.3390/life11121405.
8
An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer.卵巢癌候选治疗靶点基因概述
Cancers (Basel). 2020 Jun 4;12(6):1470. doi: 10.3390/cancers12061470.
9
Telomerase and Telomeres in Endometrial Cancer.子宫内膜癌中的端粒酶与端粒
Front Oncol. 2019 May 17;9:344. doi: 10.3389/fonc.2019.00344. eCollection 2019.
10
Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study.诊断前白细胞端粒长度与乳腺癌风险的关联:新加坡华人健康研究。
Breast Cancer Res. 2019 Apr 17;21(1):50. doi: 10.1186/s13058-019-1133-0.